Tuesday Morning Links

This and that for your Tuesday reading.

- Chance Phillips is rightly outraged that the corporate media is letting the Trump regime hand immense power to white supremacists without even calling attention to that fact. And Paul Waldman highlights how Trump's systematic misogyny is exacerbating rather than remedying the sense of dissatisfaction which has been cultivated by the right. 

- Jessica Wildfire discusses how to approach the recognition of imminent social collapse. Brian Beutler points out the importance of fighting against injustice even where victory is far from assured - both due to the possibility of succeeding, and the need to build capacity for ongoing conflicts. Jonathan Last offers his take on how to make good trouble, while pointing out how it's succeeded in reversing some of the Trump regime's abuses. And Hamilton Nolan worries that the American labour movement is crumbling due to a failure to organize broadly.  

- Cory Doctorow highlights how it's impossible to fight enshittification at the individual level, but entirely possible to do so through collective policy choices. And Brian Merchant notes that GPT-5 (among other much-hyped AI releases) is purely bait for investors rather than anything which could possibly hold value for users. 

- Garrett Graff writes that Trump's anti-science bent is destroying a multi-generation culture of research that formed the basis for the U.S.' economic success. And Arcella Martin reports on the reuse of electric vehicle batteries for grid stabilization as an example of the type of innovation and responsible resource use that's possible when governments aren't actively obstructing progress.  

- Roy Edroso explains and calls out the right's war on cities as reflecting their distate for diversity and inclusion. And Bill Fulton points out that most households could thrive with one less vehicle than they're currently paying to operate and maintain. 

- Finally, Megan Rose and Debbie Cenziper report on both the U.S.' general acquiescence in the importing of medications from banned facilities, and the process resulting in its accepting drugs from one Indian supplier with a grim safety record.